Closed |
SWOG-8791 (INT-0087) |
Adjuvant Trial of Soft Tissue Sarcomas |
3/1/1989 |
12/1/1990 |
1% |
|
|
Closed |
SWOG-7622 |
Combined Modality for Mycosis Fungoides |
8/27/1976 |
10/22/1981 |
|
|
|
Closed |
SWOG-7630 |
Chemotherapy of Advanced Prostatic Cancer |
11/22/1976 |
10/16/1979 |
|
|
|
Closed |
SWOG-7832 |
Evaluation of Chlorozotocin in Lung Cancer |
11/17/1978 |
10/17/1979 |
|
|
|
Closed |
SWOG-8051 |
Evaluation of L-Alanosine in Acute Leukemia |
4/14/1981 |
9/10/1982 |
|
|
|
Closed |
SWOG-7416 |
Chemoimmunotherapy of Adult Acute Leukemia - |
3/6/1975 |
1/1/1977 |
|
|
|
Closed |
SWOG-8939 |
Evaluation of Merbarone in Colorectal Cancer |
4/15/1990 |
7/15/1991 |
23% |
|
|
Closed |
SWOG-226 |
Phase II Protocol for Porfiromycin Solid Tumors |
7/12/1967 |
|
100% |
|
|
Closed |
SWOG-8062 |
Evaluation of Vindesine in Head and Neck Cancer |
2/25/1980 |
10/23/1981 |
|
|
|
Closed |
SWOG-7959 |
Evaluation of MGBG in Metastatic Renal Carcinoma |
12/14/1979 |
12/3/1980 |
|
|
|
Closed |
SWOG-7985 |
Combined Modality Treatment for ER - Breast Cancer |
3/3/1980 |
9/10/1982 |
|
|
|
Closed |
SWOG-8061 |
Evaluation of Vindesine in Gastrointestinal Cancer |
2/22/1980 |
9/28/1982 |
|
|
|
Closed |
SWOG-7982 |
Chlorozotocin in the Treatment of Advanced Sarcomas |
2/4/1980 |
5/11/1982 |
|
|
|
Closed |
SWOG-9147 |
Evaluation of Tamoxifen in Desmoid Tumors, Phase II |
6/1/1992 |
8/1/1996 |
35% |
|
|
Closed |
SWOG-7716 |
Study of Tamoxifen in Metastatic Renal Cell Carcinoma |
12/29/1977 |
12/28/1978 |
|
|
|
Closed |
SWOG-8014 |
Colchicine in Refractory Chronic Lymphocytic Leukemia |
7/7/1980 |
10/23/1981 |
|
|
|
Closed |
SWOG-8033 |
Trial of m-AMSA in Sarcomas of the Bone and Cartilage |
11/21/1980 |
10/23/1981 |
|
|
|
Closed |
SWOG-8206 |
Evaluation of Aclacinomycin A in Colorectal Carcinoma |
6/2/1982 |
8/25/1983 |
|
|
|
Closed |
SWOG-7632 |
Combined Modality Protocol for Recurrent Breast Cancer |
11/30/1976 |
4/14/1981 |
|
|
|
Closed |
SWOG-7833 |
Evaluation of Chlorozotocin in Gastrointestinal Cancer |
11/17/1978 |
10/16/1979 |
|
|
|